In healthtech and pharma, calculating unit economics isn't straightforward. Variables like regulatory delays, patient churn, and clinical success rates distort CAC and LTV metrics. Yet accurate modeling is critical for investor confidence and long-term viability. Understanding fixed vs variable costs, R&D amortization, and scale economics can make or break the narrative of an healthcare startup.